This gene encodes a TBP- (TATA box-binding protein) associated phosphoprotein that represses both basal and activated levels of transcription. The encoded protein is phosphorylated in vivo and this phosphorylation affects its interaction with TBP. This protein contains a histone fold motif at the amino terminus, a TBP-binding domain, and a glutamine- and alanine-rich region. The binding of DR1 repressor complexes to TBP-promoter complexes may establish a mechanism in which an altered DNA conformation, together with the formation of higher order complexes, inhibits the assembly of the preinitiation complex and controls the rate of RNA polymerase II transcription.[3]
↑Inostroza JA, Mermelstein FH, Ha I, Lane WS, Reinberg D (Sep 1992). "Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription". Cell. 70 (3): 477–89. doi:10.1016/0092-8674(92)90172-9. PMID1339312.
↑Purrello M, Di Pietro C, Rapisarda A, Viola A, Corsaro C, Motta S, Grzeschik KH, Sichel G (1996). "Genomic localization of the human gene encoding Dr1, a negative modulator of transcription of class II and class III genes". Cytogenetics and Cell Genetics. 75 (2–3): 186–9. doi:10.1159/000134479. PMID9040789.
↑Mermelstein F, Yeung K, Cao J, Inostroza JA, Erdjument-Bromage H, Eagelson K, Landsman D, Levitt P, Tempst P, Reinberg D (Apr 1996). "Requirement of a corepressor for Dr1-mediated repression of transcription". Genes Dev. 10 (8): 1033–48. doi:10.1101/gad.10.8.1033. PMID8608938.
Further reading
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Rozet JM, Gerber S, Perrault I, Camuzat A, Calvas P, Viegas-Pequignot E, Molina-Gomes D, Le Paslier D, Chumakov I, Munnich A, Kaplan J (1996). "Structure and physical mapping of DR1, a TATA-binding protein-associated phosphoprotein gene, to chromosome 1p22.1 and its exclusion in Stargardt disease (STGD)". Genomics. 36 (3): 554–6. doi:10.1006/geno.1996.0508. PMID8884286.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Kamada K, Shu F, Chen H, Malik S, Stelzer G, Roeder RG, Meisterernst M, Burley SK (2001). "Crystal structure of negative cofactor 2 recognizing the TBP-DNA transcription complex". Cell. 106 (1): 71–81. doi:10.1016/S0092-8674(01)00417-2. PMID11461703.
Gilfillan S, Stelzer G, Piaia E, Hofmann MG, Meisterernst M (2005). "Efficient binding of NC2.TATA-binding protein to DNA in the absence of TATA". J. Biol. Chem. 280 (7): 6222–30. doi:10.1074/jbc.M406343200. PMID15574413.
Lewis BA, Sims RJ, Lane WS, Reinberg D (2005). "Functional characterization of core promoter elements: DPE-specific transcription requires the protein kinase CK2 and the PC4 coactivator". Mol. Cell. 18 (4): 471–81. doi:10.1016/j.molcel.2005.04.005. PMID15893730.
Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.
Malecová B, Gross P, Boyer-Guittaut M, Yavuz S, Oelgeschläger T (2007). "The initiator core promoter element antagonizes repression of TATA-directed transcription by negative cofactor NC2". J. Biol. Chem. 282 (34): 24767–76. doi:10.1074/jbc.M702776200. PMID17584739.
